| Sample | Title | Value | Rank |
|---|
| GSM549121 | patient 080, normal, homogenized [OPG study] | 5.30368 | 46 |
| GSM549102 | patient 115, normal, homogenized [OPG study] | 5.53949 | 50 |
| GSM549104 | patient 119, normal, homogenized [OPG study] | 4.99575 | 40 |
| GSM549108 | patient 138, normal, homogenized [OPG study] | 5.31101 | 45 |
| GSM549119 | patient 077, normal, homogenized [OPG study] | 5.04802 | 41 |
| GSM549133 | patient 032, cancer, homogenized [OPG study] | 5.06466 | 43 |
| GSM549139 | patient 042, cancer, homogenized [OPG study] | 4.92674 | 39 |
| GSM549099 | patient 107, normal, homogenized [OPG study] | 5.54112 | 50 |
| GSM549109 | patient 139, normal, homogenized [OPG study] | 4.95941 | 39 |
| GSM549110 | patient 046, normal, homogenized [OPG study] | 5.01233 | 40 |
| GSM549114 | patient 063, normal, homogenized [OPG study] | 5.47483 | 50 |
| GSM549122 | patient 082, normal, homogenized [OPG study] | 5.14964 | 43 |
| GSM549134 | patient 033, cancer, homogenized [OPG study] | 5.21654 | 45 |
| GSM549136 | patient 036, cancer, homogenized [OPG study] | 4.78266 | 37 |
| GSM549140 | patient 044, cancer, homogenized [OPG study] | 4.83763 | 38 |
| GSM549111 | patient 047, normal, homogenized [OPG study] | 4.92548 | 39 |
| GSM549113 | patient 057, normal, homogenized [OPG study] | 5.10631 | 43 |
| GSM549132 | patient 031, cancer, homogenized [OPG study] | 4.82494 | 37 |
| GSM549137 | patient 038, cancer, homogenized [OPG study] | 4.89906 | 39 |
| GSM549142 | patient 047, cancer, homogenized [OPG study] | 5.23465 | 42 |
| GSM549100 | patient 110, normal, homogenized [OPG study] | 5.45168 | 49 |
| GSM549107 | patient 135, normal, homogenized [OPG study] | 5.02083 | 41 |
| GSM549115 | patient 068, normal, homogenized [OPG study] | 5.26265 | 47 |
| GSM549116 | patient 072, normal, homogenized [OPG study] | 5.03677 | 41 |
| GSM549120 | patient 078, normal, homogenized [OPG study] | 5.32177 | 47 |
| GSM549131 | patient 030, cancer, homogenized [OPG study] | 4.96012 | 41 |
| GSM549118 | patient 074, normal, homogenized [OPG study] | 5.22319 | 45 |
| GSM549129 | patient 027, cancer, homogenized [OPG study] | 4.82316 | 36 |
| GSM549123 | patient 088, normal, homogenized [OPG study] | 4.94883 | 40 |
| GSM549124 | patient 006, cancer, homogenized [OPG study] | 4.92405 | 38 |
| GSM549126 | patient 015, cancer, homogenized [OPG study] | 4.9233 | 39 |
| GSM549128 | patient 025, cancer, homogenized [OPG study] | 4.74019 | 35 |
| GSM549103 | patient 117, normal, homogenized [OPG study] | 5.41234 | 47 |
| GSM549117 | patient 073, normal, homogenized [OPG study] | 5.26541 | 46 |
| GSM549138 | patient 041, cancer, homogenized [OPG study] | 4.80861 | 37 |
| GSM549141 | patient 045, cancer, homogenized [OPG study] | 4.8479 | 38 |
| GSM549130 | patient 028, cancer, homogenized [OPG study] | 5.17008 | 44 |
| GSM549101 | patient 111, normal, homogenized [OPG study] | 5.1612 | 43 |
| GSM549105 | patient 128, normal, homogenized [OPG study] | 5.17996 | 43 |
| GSM549106 | patient 134, normal, homogenized [OPG study] | 4.9491 | 40 |
| GSM549112 | patient 048, normal, homogenized [OPG study] | 5.13805 | 43 |
| GSM549125 | patient 011, cancer, homogenized [OPG study] | 5.05962 | 41 |
| GSM549127 | patient 024, cancer, homogenized [OPG study] | 4.79063 | 36 |
| GSM549135 | patient 035, cancer, homogenized [OPG study] | 4.95173 | 40 |